Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma. - Wikidata - wikimedia - TriplyDB

Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma.

Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma.

http://www.wikidata.org/entity/Q36105152

about

Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics Emerging Transcriptional Mechanisms in the Regulation of Epithelial to Mesenchymal Transition and Cellular Plasticity in the Kidney The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial-mesenchymal transition-related proteins.Long noncoding RNA-EBIC promotes tumor cell invasion by binding to EZH2 and repressing E-cadherin in cervical cancer Designing biomarker studies for head and neck cancer.Regulation and Role of EZH2 in Cancer The clinicopathological significance of epithelial mesenchymal transition associated protein expression in head and neck squamous cell carcinoma.Enhancer of zeste homolog 2 is involved in the proliferation of endometrial carcinoma.Quantitative analysis of EZH2 expression and its correlations with lung cancer patients' clinical pathological characteristics.Enhancer of zeste homolog 2 as an independent prognostic marker for cancer: a meta-analysis Decreased miR-320a promotes invasion and metastasis of tumor budding cells in tongue squamous cell carcinoma.MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer.EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer.The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer.Somatic evolution of head and neck cancer - biological robustness and latent vulnerability.De-repressing LncRNA-Targeted Genes to Upregulate Gene Expression: Focus on Small Molecule Therapeutics Role of EZH2 protein expression in gastric carcinogenesis among Asians: a meta-analysis.LncRNA-ANCR down-regulation suppresses invasion and migration of colorectal cancer cells by regulating EZH2 expression.Epigenetic regulation of E-cadherin expression by the histone demethylase UTX in colon cancer cells.Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer.EZH2 regulates cancer cell migration through repressing TIMP-3 in non-small cell lung cancer.Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.Polycomb Repressor Complex 2 in Genomic Instability and Cancer Effects of EZH2 gene on the growth and migration of hepatocellular carcinoma HepG2 cells The H3K27me3-demethylase KDM6A is suppressed in breast cancer stem-like cells, and enables the resolution of bivalency during the mesenchymal-epithelial transition.E-cadherin expression and prognosis of oral cancer: a meta-analysis.Activation of adrenergic receptor β2 promotes tumor progression and epithelial mesenchymal transition in tongue squamous cell carcinoma.Epigenetic analysis of FHL1 tumor suppressor gene in human liver cancer.SOX4 arrests lung development in rats with hyperoxia‑induced bronchopulmonary dysplasia by controlling EZH2 expression.Patients with advanced oral squamous cell carcinoma have high levels of soluble E-cadherin in the saliva.The involvement of lncRNAs in the development and progression of pancreatic cancer.Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct.hMOF (human males absent on the first), an oncogenic protein of human oral tongue squamous cell carcinoma, targeting EZH2 (enhancer of zeste homolog 2).Epigenetic Contribution of High-Mobility Group A Proteins to Stem Cell Properties.Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling

P2860

Q26753032-F646CE8F-A368-4D86-954D-110D1242CF68 Q26771698-BF42FFF6-3059-49A1-8E79-29A360E65400 Q26775618-C132A904-5333-49C3-9184-32FA88B2DB74 Q33751870-4E9DAF15-B831-4715-BDC7-C422807C9B8B Q33875021-81DA06E5-F9CB-4DEA-83A0-62D60C3652DA Q33971467-F61120D1-3524-4C6B-976B-9DADCCC83412 Q34043370-D31812EC-06DD-400F-8D01-913D00AB7C3A Q34161925-FCF39259-E25D-41C4-8B96-D7EE5A39226D Q34293217-15731FC5-F587-4494-92A6-6FF4E9DAD488 Q34362220-C1CE0DA5-1736-49FD-A80E-FC123C5AC0C9 Q35606640-0C494052-5A24-49CA-899C-7F35D1F5064A Q36119364-DE383639-AC0F-450F-8F7F-E7AAE0F1C3F0 Q36433424-A93211C7-974C-495D-9D5F-B368DC28EC30 Q36962787-E5BAFBE9-73B1-44A3-A64A-F744AB4AB2D1 Q36998193-B6FE3141-8D31-4F9E-8075-F9EFBF7F93A9 Q37589165-6BA2B908-05C2-4CB0-A371-CA41F451EF2F Q38061224-49934E85-9FC1-4024-BD9C-E78537355687 Q38269075-BE8ABF63-9624-48ED-8F7D-DE2F5D075784 Q38398580-4B29598D-B059-4796-A582-C5A15EECFFB6 Q38725914-373325B8-B5DA-40B3-943F-EF79336EF4EB Q38798997-D8CAC2A0-FDA5-49A0-B7DF-55EC9F441A77 Q38950245-842D03DB-0D56-42BB-ADB5-3D625FB577B0 Q39077650-561C5A97-2E96-4955-9A0B-6E8A191A038B Q39254523-F1D80219-9E0B-4081-B1D6-FB9DF601CBA0 Q41573279-DA05E377-FE03-49D7-9AA5-C831BFC75297 Q41955698-64AAE18B-5FFF-4CFE-9716-ED0221F59AC5 Q42371555-074628CD-8E39-4F1F-967F-C4764CDD0B80 Q46654328-1F8B7B91-B955-408F-B553-3B2CF2804DA9 Q47104680-44806A98-79A1-45C3-A6B6-7609FD59F57E Q47129854-04ABDE8B-987A-48FF-92A3-2464AE18F4CC Q47159551-D0741AD3-D0CA-4C1C-841B-6321352711A8 Q47624231-F5CA18A6-1DC7-4CFB-B3F6-2E1B7EF1EEFF Q47624410-68D90E29-A35A-49AA-B7F8-2D9CE6007578 Q51295478-F37E99C1-733C-4E76-98B1-379A7B82B69B Q53669155-F8B6118A-8520-4B67-B79C-A0752C265C20 Q55106988-C11D6F1D-149F-4ED7-A493-C7A06821E668 Q58704446-701F3F9F-3DFD-449C-8187-1699F90D8B5E

P2860

Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma.

http://www.wikidata.org/entity/Q36105152

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Polycomb group protein EZH2-me ...... ongue squamous cell carcinoma.

@ast

Polycomb group protein EZH2-me ...... ongue squamous cell carcinoma.

@en

type

label

Polycomb group protein EZH2-me ...... ongue squamous cell carcinoma.

@ast

Polycomb group protein EZH2-me ...... ongue squamous cell carcinoma.

@en

prefLabel

Polycomb group protein EZH2-me ...... ongue squamous cell carcinoma.

@ast

Polycomb group protein EZH2-me ...... ongue squamous cell carcinoma.

@en

P1433

Q36105152-DC2F20D5-DC3D-4117-8AB8-2A0CA299C425

P1476

Q36105152-4810A718-22FB-45A3-A45B-36732B746C26

P2093

Q36105152-0957D541-81A2-4C30-BB0C-5D70EAD34EBF

Q36105152-17CB5A8D-89EE-44EF-AAC5-8254CE0B5A57

Q36105152-5E9D26FA-5171-4BA4-937E-502A26B64B54

Q36105152-64AEB937-7E2F-4C56-BC0F-153613E98C0A

Q36105152-6B753882-280B-4DEA-B311-4D56F98FF5C4

Q36105152-ACEB7BCE-DD14-4031-B79D-8B91DD3261B6

Q36105152-B08A12C9-7225-4CD0-A4EC-EF39B6E14205

Q36105152-BDD2931E-85DC-4902-9A32-E0499D9D1ABA

Q36105152-C9F8E420-0140-42BD-A39A-CA6C271A4112

Q36105152-E07AA1AE-E5F5-4400-9EB3-9D7ECB9F5A5A

P2860

Q36105152-1D1EF68A-B0F5-47B7-B170-4C5969D18164

Q36105152-1E6F351E-FB4F-40C2-9553-22CCDBD830F3

Q36105152-2588615B-AEC0-410C-9BFC-38C11CD04A08

Q36105152-2832B6F1-4D44-4040-888A-DA39B5F66BAF

Q36105152-3CAE7085-ED13-48AB-A132-C8CE2092AD2C

Q36105152-4CB41EFE-6061-4FAA-8EDB-06B86BEEE3F3

Q36105152-614EFA87-FF9D-44E7-B5A9-93453CB59C75

Q36105152-6625A79F-E09E-49D9-BFE7-6CE44EF057F2

Q36105152-82403A8F-FC1C-45D7-88E7-7120A331EFFC

Q36105152-903DBC3F-9881-4CB5-BA33-1887B2A60ABB

P304

Q36105152-C4DAFC8A-41F5-4EC7-B393-17F99EB2FB19

P31

Q36105152-C18C4314-48DE-4427-A69F-72E3107F655C

P356

Q36105152-3BE86C58-04B7-4368-9E38-DAB35DB9123A

P433

Q36105152-6F2DB2EF-223C-4D01-8B29-5CB8EAE42484

P478

Q36105152-D1E6070F-2588-4FC1-84F8-D8FE902E48BD

P577

Q36105152-A8F1035C-B8EA-4517-BAEF-4362FC551604

P698

Q36105152-BC8767AC-F010-4418-896C-EA6EA3B072BD

P932

Q36105152-6F832409-03D8-4119-BEAB-C179B9135C2D

P356

P1433

Molecular Carcinogenesis

P1476

Polycomb group protein EZH2-me ...... ongue squamous cell carcinoma.

@en

P2093

Antonia Kolokythas

http://www.w3.org/2001/XMLSchema#string

Anxun Wang

http://www.w3.org/2001/XMLSchema#string

Cheng Wang

http://www.w3.org/2001/XMLSchema#string

David T W Wong

http://www.w3.org/2001/XMLSchema#string

Hongzhang Huang

http://www.w3.org/2001/XMLSchema#string

Xiaofeng Zhou

http://www.w3.org/2001/XMLSchema#string

Xiqiang Liu

http://www.w3.org/2001/XMLSchema#string

Yang Dai

http://www.w3.org/2001/XMLSchema#string

Yi Jin

http://www.w3.org/2001/XMLSchema#string

Zujian Chen

http://www.w3.org/2001/XMLSchema#string

P2860

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin

Cancer statistics, 2010

The polycomb group protein EZH2 is involved in progression of prostate cancer

Polycomb silencers control cell fate, development and cancer

Dysregulation of heat shock protein 27 expression in oral tongue squamous cell carcinoma

MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines.

Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma.

MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines

Occult lymph node metastasis in small oral tongue cancers.

P304

229-236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MC.21848

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22161744

http://www.w3.org/2001/XMLSchema#string

P932

3400713

http://www.w3.org/2001/XMLSchema#string